Cortisol in Long COVID

Cortisol, also described as Glucocorticoid, is a proteomic marker with mixed findings in Long COVID (PASC, Post-Acute Sequelae of COVID-19): studies comparing patients with healthy controls report both increases and decreases. The cited literature links this alteration to HPA axis dysregulation. The evidence summarised here comes from Baalbaki et al. 2025 and reflects averages across cohorts rather than any single patient's result.

↕ InconsistentProteomicLOINC 2143-6

Summary

Direction in Long COVID↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryProteomic
Also described asGlucocorticoid
Compared againstHC (healthy controls)
Associated symptomsHPA axis dysregulation
Test typeBlood test (serum / plasma / whole blood)
LOINC code2143-6
SourceBaalbaki et al. 2025 — doi:10.1111/all.16526
Condition atlasLong COVID Biomarker Atlas

Other conditions where Cortisol is reported

Atlas entryDirectionCompared against
Cortisol (diurnal) in Gulf War Illness↕ inconsistentvs HGV
Cortisol in Major Depressive Disorder↑ elevatedvs MDD patients vs healthy controls (HPA axis dysregulation)
Cortisol (diurnal rhythm) in ME/CFS↕ inconsistentvs HC

See the cross-condition hub: Cortisol across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Cortisol Level (15 registered trials use a matching outcome measure).

Clinical trials using Cortisol as an outcome

NCT06928480Recruiting
Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.
Outcome measure: Cortisol and cortisona levels
NCT05795816Completed
Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms
Outcome measure: Change in Pathology results via Blood test
NCT05630040Completed
VNS for Long-COVID-19
Outcome measure: Morning salivary cortisol levels
Effectiveness of Non-invasive Neuromodulation in Patients With Long-COVID
Outcome measure: Cortisol and alpha amylase levels
FMT for Post-acute COVID-19 Syndrome
Outcome measure: Change in blood cortisol
Non-pharmacological and TCM-based Treatment for Long COVID Symptoms
Outcome measure: Neurobiological outcomes
Vagus Stimulation in Female Long COVID Patients.
Outcome measure: Saliva cortisol
Physiotherapy for Persistent Function by Superficial Neuromodulation
Outcome measure: Cortisol levels

7 more trials reference this marker.

Interventions studied alongside this marker

Hypothesis-generating links from trial outcome usage and literature co-occurrence. Not treatment recommendations.

Commercial test availability

Cortisol — commercial laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Proteomic markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is Cortisol high or low in Long COVID?

Mixed. Some studies report higher and others lower Cortisol in Long COVID compared with healthy controls, so no single direction is established. Source: Baalbaki et al. 2025.

What symptoms is Cortisol associated with in Long COVID?

The cited literature associates this marker with HPA axis dysregulation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Cortisol?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 2143-6. Commercial laboratories such as Quest Diagnostics, LabCorp, Ulta Lab Tests list an orderable assay.

Is one abnormal Cortisol result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. Cortisol findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Cortisol specific to Long COVID?

No. The same marker is also reported in Gulf War Illness, ME/CFS, Major Depressive Disorder in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Cortisol in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/cortisol.html

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.